Comparing Agilon Health (AGL) and The Competition

Agilon Health (NYSE:AGL) is one of 233 publicly-traded companies in the “Healthcare Providers & Services” industry, but how does it weigh in compared to its competitors? We will compare Agilon Health to similar businesses based on the strength of its dividends, institutional ownership, earnings, risk, analyst recommendations, profitability and valuation.

Insider & Institutional Ownership

56.7% of shares of all “Healthcare Providers & Services” companies are owned by institutional investors. 2.5% of Agilon Health shares are owned by company insiders. Comparatively, 15.0% of shares of all “Healthcare Providers & Services” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Agilon Health and its competitors, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilon Health	2	6	6	0	2.29
Agilon Health Competitors	1861	7721	13337	820	2.55

Agilon Health currently has a consensus price target of $102.25, indicating a potential downside of 10.84%. As a group, “Healthcare Providers & Services” companies have a potential upside of 14.04%. Given Agilon Health’s competitors stronger consensus rating and higher possible upside, analysts clearly believe Agilon Health has less favorable growth aspects than its competitors.

Dividends

Agilon Health pays an annual dividend of $1.80 per share and has a dividend yield of 1.6%. Agilon Health pays out -32.4% of its earnings in the form of a dividend. As a group, “Healthcare Providers & Services” companies pay a dividend yield of 1.4% and pay out 25.9% of their earnings in the form of a dividend. Agilon Health is clearly a better dividend stock than its competitors, given its higher yield and lower payout ratio.

Volatility & Risk

Agilon Health has a beta of 3.1, indicating that its stock price is 210% more volatile than the S&P 500. Comparatively, Agilon Health’s competitors have a beta of 0.98, indicating that their average stock price is 2% less volatile than the S&P 500.

Valuation and Earnings

This table compares Agilon Health and its competitors top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Agilon Health	$6.00 billion	-$391.35 million	-20.66
Agilon Health Competitors	$19.16 billion	$301.67 million	7.54

Agilon Health’s competitors have higher revenue and earnings than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Agilon Health and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Agilon Health	-1.45%	-51.97%	-7.15%
Agilon Health Competitors	-8.08%	-137.95%	-1.47%

Summary

Agilon Health competitors beat Agilon Health on 10 of the 15 factors compared.

About Agilon Health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.